Citigroup »

Bridgebio Pharma shares owned by Citigroup

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $66M 1.6M 40.37
2023-09-30 $43M 1.6M 26.37
2023-03-31 $26M 1.6M 16.58
2022-12-31 $11M 1.4M 7.62
2022-09-30 $16M 1.6M 9.94
2021-12-31 $20M 1.2M 16.68
2021-03-31 $37M 603k 61.60
2020-12-31 $38M 540k 71.11
2020-09-30 $27M 726k 37.52
2020-06-30 $26M 811k 32.61
2020-03-31 $3.4M 117k 29.00
2019-12-31 $874k 25k 35.01
2019-09-30 $21k 1.0k 20.59